Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children
This study has been completed.
Study NCT01254175   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on December 2, 2010.   Last Updated on December 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Parainfluenza Virus 3, Human
Additional conditions recognized in this trial
Paramyxoviridae Infections
Virus Diseases
More general conditions related to this trial
Mononegavirales Infections
RNA Virus Infections
Interventions listed in this trial
rHPIV3cp45 Vaccine
Placebo Vaccine
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services